GRAIL, Inc. has grown revenue 38% a year over three years and 38% a year over five. Revenue growth, 3-year annual rate: +38% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +38%, growth has slowed since the five-year average. Years of annual history on file: 4, FY2022 to FY2025, as filed.

GRALGRAIL, Inc.

HealthcareUSD

$79.59

$31.4252 weeks$116.06

Is it growing?

Is GRAL growing?

GRAIL, Inc. has grown revenue 38% a year over three years and 38% a year over five.

+38%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +38%
Revenue growth, 5-year rate · +38% over three · growth has slowed since the five-year average
Years of annual history on file: 4
Years of annual history on file · FY2022 to FY2025, as filed

Details›